← Back to catalogue

BD Onclarity™ HPV Assay Reagent Pack

FDA UDI

Class III (US FDA UDI)

by Becton Dickinson And Company

Identity

Trade Name
BD Onclarity™ HPV Assay Reagent Pack FDA UDI
Generic Name
Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI
Device Name
Kit HPV Assay Reagent for BD COR US FDA UDI
Model / Reference
444075 FDA UDI
Description
Kit HPV Assay Reagent for BD COR US FDA UDI

Identifiers

Catalog Number
444075 FDA UDI
Primary DI / UDI-DI
00382904440756 FDA UDI
PMA Number
P160037 FDA UDI
FDA Product Code
MAQ FDA UDI
GMDN Term
Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT) FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT)

BD Onclarity™ HPV Assay Reagent Pack by Becton Dickinson And Company — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Human papillomavirus (HPV) nucleic acid IVD, kit, nucleic acid technique (NAT).

Cleared under the same submission

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 6bc1e4b5-19fe-4b00-a5c3-49707fcedb06 37 fields · synced May 30, 2026